GRAIL Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
View Press Release
12/03/2024
GRAIL to Participate in Upcoming Investor Conferences
View Press Release
11/19/2024
GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study
View Press Release
11/18/2024
GRAIL Reports Third Quarter 2024 Financial Results
View Press Release
11/12/2024
GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
View Press Release
11/04/2024
GRAIL to Announce Third Quarter 2024 Financial Results
View Press Release
10/29/2024